000			01395 a2200409 4500
005			20250515201124.0
264		0	_c20100608
008			201006s 0 0 eng d
022			_a1600-0641
024	7		_a10.1016/j.jhep.2009.10.028 _2doi
040			_aNLM _beng _cNLM
100	1		_aDonato, C
245	0	0	_aInsulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients. _h[electronic resource]
260			_bJournal of hepatology _cFeb 2010
300			_a306-7 p. _bdigital
500			_aPublication Type: Letter; Comment
650	0	4	_aAdult
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHepatitis C _xcomplications
650	0	4	_aHumans
650	0	4	_aInsulin Resistance
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aMale
650	0	4	_aPolyethylene Glycols _xtherapeutic use
650	0	4	_aRecombinant Proteins
650	0	4	_aRetrospective Studies
650	0	4	_aRibavirin _xtherapeutic use
650	0	4	_aTreatment Outcome
700	1		_aCingolani, A
700	1		_aPinnetti, C
700	1		_aDe Luca, A
773	0		_tJournal of hepatology _gvol. 52 _gno. 2 _gp. 306-7
856	4	0	_uhttps://doi.org/10.1016/j.jhep.2009.10.028 _zAvailable from publisher's website
999			_c19388452 _d19388452